New Medicines Fund (Access to Ivacaftor) To ask the Scottish Government what consideration it has given to using the new medicines fund to ensure access to the cystic fibrosis medicine, Ivacaftor, for two to five-year-olds with the G551D gene. (S5O-00010) The new medicines fund can be used by NHS boards to support the cost of that treatment.